Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹2,319 Cr
up ₹140 Cr vs Jan 2024
- Stocks held
- 26
- down 1 vs Jan 2024
- Top 10 weight
- 67.8%
- of the portfolio in its ten largest
- Cash & debt
- 1.9%
- cash, money market and debt
- Moves this month
- 0 in · 1 out
- added to 10, trimmed 9
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In February 2024 it disclosed 26 stocks worth ₹2,319 Cr, up ₹140 Cr from Jan 2024. Its largest positions were Sun Pharmaceutical Industries Limited (13.9%), Cipla Limited (8.2%), IPCA Laboratories Limited (8.0%); the ten largest together made up 67.8% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 70.8% of its equity. Cash and debt stood at 1.9%. Compared with Jan 2024 the fund entered 0 new stocks and exited 1.
Against 229 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
10%
Holds more stocks than 10% of peers
Cash
28%
Holds more cash than 28% of peers
What these mean: concentration · cash
Holdings in February 2024
Download CSVEvery line the fund disclosed, with the change against Jan 2024. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 13.87% | up 0.60 pts | ₹322 Cr | up ₹32.5 Cr | Added |
| Cipla Limited | 8.20% | up 0.24 pts | ₹190 Cr | up ₹16.6 Cr | Added |
| IPCA Laboratories Limited | 8.01% | up 0.01 pts | ₹186 Cr | up ₹11.4 Cr | Added |
| Lupin Limited | 7.64% | up 0.09 pts | ₹177 Cr | up ₹12.6 Cr | Added |
| Suven Pharmaceuticals Limited | 7.60% | down 0.46 pts | ₹176 Cr | up ₹53 L | Held |
| Alembic Pharmaceuticals Limited | 5.94% | down 0.01 pts | ₹138 Cr | up ₹8 Cr | Added |
| Apollo Hospitals Enterprise Limited | 4.90% | down 0.53 pts | ₹114 Cr | down ₹4.7 Cr | Trimmed |
| Globus Medical Inc | 4.29% | down 0.18 pts | ₹99.4 Cr | up ₹2 Cr | Added |
| Concord Biotech Limited | 3.92% | down 0.25 pts | ₹90.9 Cr | up ₹1 L | Held |
| Procter & Gamble Health Limited | 3.48% | down 0.25 pts | ₹80.8 Cr | down ₹66 L | Trimmed |
| Zydus Lifesciences Limited | 3.36% | up 0.47 pts | ₹77.9 Cr | up ₹15 Cr | Added |
| Alkem Laboratories Limited | 3.22% | down 1.08 pts | ₹74.7 Cr | down ₹19 Cr | Trimmed |
| Vijaya Diagnostic Centre Limited | 2.83% | down 0.26 pts | ₹65.7 Cr | down ₹1.6 Cr | Trimmed |
| Kovai Medical Center and Hospital Limited | 2.81% | up 0.37 pts | ₹65.1 Cr | up ₹11.9 Cr | Added |
| Intuitive Surgical Inc | 2.59% | down 0.12 pts | ₹60 Cr | up ₹1 Cr | Added |
| Indoco Remedies Limited | 2.55% | down 0.34 pts | ₹59.1 Cr | down ₹3.9 Cr | Trimmed |
| Cash, TREPS & receivables | 1.87% | up 0.95 pts | ₹43.3 Cr | up ₹23.4 Cr | Added |
| ICICI Lombard General Insurance Company Limited | 1.78% | up 0.12 pts | ₹41.3 Cr | up ₹5.2 Cr | Added |
| Unichem Laboratories Limited | 1.65% | up 0.07 pts | ₹38.2 Cr | up ₹3.7 Cr | Added |
| Aarti Drugs Limited | 1.58% | down 0.20 pts | ₹36.7 Cr | down ₹2.1 Cr | Trimmed |
| Narayana Hrudayalaya Limited | 1.46% | up 0.94 pts | ₹33.7 Cr | up ₹22.5 Cr | Added |
| Taro Pharmaceutical Industries Limited | 1.35% | down 0.12 pts | ₹31.2 Cr | down ₹79 L | Trimmed |
| Abbott Laboratories | 1.34% | down 0.02 pts | ₹31.1 Cr | up ₹1.4 Cr | Added |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 1.11% | up 0.05 pts | ₹25.7 Cr | up ₹2.6 Cr | Added |
| Illumina Inc | 1.02% | down 0.09 pts | ₹23.7 Cr | down ₹58 L | Trimmed |
| MedPlus Health Services Limited | 0.58% | down 0.06 pts | ₹13.4 Cr | down ₹39 L | Trimmed |
| Jupiter Life Line Hospitals Limited | 0.57% | up 0.10 pts | ₹13.3 Cr | up ₹3.1 Cr | Added |
| Pfizer Limited | 0.50% | up 0.20 pts | ₹11.7 Cr | up ₹5.1 Cr | Added |
What changed, Jan 2024 to Feb 2024
New New positions (0)
None.
Exited Exited (1)
- Mankind Pharma Limitedwas 0.2% · ₹4.8 Cr
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹32.5 Cr (+0.60% pts)
- Narayana Hrudayalaya Limitedup ₹22.5 Cr (+0.94% pts)
- Cipla Limitedup ₹16.6 Cr (+0.24% pts)
- Zydus Lifesciences Limitedup ₹15 Cr (+0.47% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jan 2024, the weight rose most in Healthcare Services (+0.7 pts) and Insurance (+0.1 pts), and fell most in Pharmaceuticals & Biotechnology (−0.3 pts) and Pharmaceuticals (−0.2 pts).
- Healthcare Services13.3% → 14.0%+0.7 pts
- Insurance1.7% → 1.8%+0.1 pts
- Pharmaceuticals & Biotechnology71.1% → 70.8%−0.3 pts
- Pharmaceuticals6.0% → 5.7%−0.2 pts
- Healthcare Equipment & Supplies7.3% → 7.1%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Feb 2021 | Feb 2023 | Aug 2023 | Nov 2023 | Jan 2024 | Feb 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 63.9% | 68.0% | 74.6% | 73.5% | 71.1% | 70.8% |
| Healthcare Services | 22.3% | 16.8% | 11.7% | 12.0% | 13.3% | 14.0% |
| Healthcare Equipment & Supplies | 3.3% | 5.8% | 5.0% | 6.1% | 7.3% | 7.1% |
| Pharmaceuticals | 7.2% | 6.0% | 5.7% | 5.7% | 6.0% | 5.7% |
| Insurance | 3.4% | 2.3% | 2.0% | 1.9% | 1.7% | 1.8% |
| Retailing | — | 1.1% | 1.0% | 0.8% | 0.6% | 0.6% |
Allocation in Feb 2024change vs Jan 2024
- Pharmaceuticals & Biotechnology (13)70.8%▼ 0.3 pts
- Healthcare Services (6)14.0%▲ 0.7 pts
- Healthcare Equipment & Supplies (2)7.1%▼ 0.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Feb 2024
1.9%
▲ 1.0 pts vs Jan 2024
- Cash alone
- 1.9%
- cash and net receivables
- A year earlier
- 0.5%
- Feb 2023 · now ▲ 1.3 pts
- Last 12 months
- <0.1% – 3.2%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.